186
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Variation of asthma characteristics with atopic march, gastroesophageal reflux, and ENT pathologies

, MD, , PhD & , MD
Pages 1661-1667 | Received 26 Oct 2022, Accepted 24 Jan 2023, Published online: 27 Feb 2023

References

  • Perry R, Braileanu G, Palmer T, Stevens P. The economic burden of pediatric asthma in the United States: literature review of current evidence. Pharmacoeconomics. 2019;37(2):155–167. doi:10.1007/s40273-018-0726-2.
  • Emergency department visits: CDC/NCHS. National Hospital Ambulatory Medical CareSurvey (NHAMCS): 2010–2018. https://www.cdc.gov/nchs/ahcd/about_ahcd.htm.
  • Centers for Disease Control and Prevention. 2020. 2019 National Health Interview Surveydata. U.S. Department of Health & Human Services. Available from: https://www.cdc.gov/asthma/nhis/2019/data.htm.
  • Stern DA, Morgan WJ, Halonen M, Wright AL, Martinez FD. Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: alongitudinal birth-cohort study. Lancet. 2008;372(9643):1058–1064. doi:10.1016/S0140-6736(08)61447-6.
  • Bantz SK, Zhu Z, Zheng T. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. J Clin Cell Immunol. 2014;5(2):202. doi:10.4172/2155-9899.1000202.
  • Simpson AB, Glutting J, Yousef E. Food allergy and asthma morbidity in children. Pediatr Pulmonol. 2007;42(6):489–495. doi:10.1002/ppul.20605.
  • National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol. 2007;120(5 Suppl):S94–S138.
  • Kapur S, Watson W, Carr S. Atopic dermatitis. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):52. doi:10.1186/s13223-018-0281-6.
  • Halkjaer LB, Loland L, Buchvald FF, Agner T, Skov L, Strand M, Bisgaard H. Development of atopic dermatitis during the first 3 years of life: the Copenhagen prospective study on asthma in childhood cohort study in high-risk children. Arch Dermatol. 2006;142(5):561–566. doi:10.1001/archderm.142.5.561.
  • Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatovener (Stockholm). 1980;92:44–47. doi:10.2340/00015555924447.
  • Bégin P, Nadeau KC. Diagnosis of food allergy. Pediatr Ann. 2013;42(6):102–109. doi:10.3928/00904481-20130522-10.
  • Small P, Keith PK, Kim H. Allergic rhinitis. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):51. doi:10.1186/s13223-018-0280-7.
  • Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001;108(1 Suppl):S2–S8. doi:10.1067/mai.2001.115569.
  • Rosen R. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66(3):516–554.
  • Baron SE, Cohen SN, Archer CB, British Association of Dermatologists and Royal College of General Practitioners. Guidance on the diagnosis and clinical management of atopic eczema. Clin Exp Dermatol. 2012;37:7–12. doi:10.1111/j.1365-2230.2012.04336.x.
  • Kusel MM, Holt PG, de Klerk N, Sly PD. Support for 2 variants of eczema. J Allergy Clin Immunol. 2005;116(5):1067–1072. doi:10.1016/j.jaci.2005.06.038.
  • Yang L, Fu J, Zhou Y. Research progress in atopic march. Front Immunol. 2020;11:1907. doi:10.3389/fimmu.2020.01907.
  • Froidure A, Mouthuy J, Durham SR, Chanez P, Sibille Y, Pilette C. Asthma phénotypes and IgE réponses. Eur Respir J. 2016;47(1):304–319. doi:10.1183/13993003.01824-2014.
  • Enomoto H, Hirata K, Otsuka K, Kawai T, Takahashi T, Hirota T, Suzuki Y, Tamari M, Otsuka F, Fujieda S, et al. Filaggrin null mutations are associated with atopic dermatitis and elevated levels of IgE in the Japanese population: a family and case-control study. J Hum Genet. 2008;53(7):615. doi:10.1007/s10038-008-0293-z.
  • Ekbäck M, Tedner M, Devenney I, Oldaeus G, Norrman G, Strömberg L, Fälth-Magnusson K. Severe eczema in infancy can predict asthma development. A prospective study to the age of 10 years. PLoS One. 2014;9(6):e99609. doi:10.1371/journal.pone.0099609.
  • Severity Scoring of Atopic Dermatitis: The SCORAD Index. Consensus report of the European task force on atopic dermatitis. Dermatology. 1993;186:23–31. doi:10.1159/000247298.
  • Saunes M, Øien T, Dotterud CK, Romundstad PR, Storrø O, Holmen TL, Johnsen R. Early eczema and the risk of childhood asthma: a prospective, population-based study. BMC Pediatr. 2012;12:168. doi:10.1186/1471-2431-12-168.
  • Shamssain MH, Shamsian N. Prevalence and severity of asthma, rhinitis, and atopic eczema: the northeast study. Arch Dis Child. 1999;81(4):313–317. doi:10.1136/adc.81.4.313.
  • Maciag MC, Phipatanakul W. Preventing the development of asthma: stopping the allergic march. Curr Opin Allergy Clin Immunol. 2019;19(2):161–168. doi:10.1097/ACI.0000000000000501.
  • Simons FE. Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC Study Group. Early Treatment of the Atopic Child. J Allergy Clin Immunol. 1999;104(2):433–440. doi:10.1016/S0091-6749(99)70389-1.
  • Schneider L, Hanifin J, Boguniewicz M, Eichenfield LF, Spergel JM, Dakovic R, Paller AS. Study of the atopic march: development of atopic comorbidities. Pediatr Dermatol. 2016;33(4):388–398. doi:10.1111/pde.12867.
  • Novembre E, Galli E, Landi F, Caffarelli C, Pifferi M, De Marco E, Burastero SE, Calori G, Benetti L, Bonazza P, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhino conjunctivitis. J Allergy Clin Immunol. 2004;114(4):851–857. doi:10.1016/j.jaci.2004.07.01.
  • Agache I, Beltran J, Akdis C, Akdis M, Canelo-Aybar C, Canonica GW, Casale T, Chivato T, Corren J, Del Giacco S, et al. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines – recommendations on the use of biologicals in severe asthma. Allergy. 2020;75(5):1023–1042. doi:10.1111/all.14221.
  • Busse WW, Morgan WJ, Gergen PJ, Mitchell HE, Gern JE, Liu AH, Gruchalla RS, Kattan M, Teach SJ, Pongracic JA, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med. 2011;364(11):1005–1015. doi:10.1056/NEJMoa1009705.
  • Tiotiu A, Plavec D, Novakova S, Mihaicuta S, Novakova P, Labor M, Bikov A. Current opinions for the management of asthma associated with ear, nose and throat comorbidities. Eur Respir Rev. 2018;27(150):180056. doi:10.1183/16000617.0056-2018.
  • Anfuso A, Ramadan H, Terrell A, Demirdag Y, Walton C, Skoner DP, Piedimonte G. Sinus and adenoid inflammation in children with chronic rhinosinusitis and asthma. Ann Allergy Asthma Immunol. 2015;114(2):103–110. doi:10.1016/j.anai.2014.10.024.
  • Thakkar K, Boatright RO, Gilger MA, El-Serag HB. Gastroesophageal reflux and asthma in children: a systematic review. Pediatrics. 2010;125(4):e925–e930. doi:10.1542/peds.2009-238.
  • Parsons JP, Mastronarde JG. Gastroesophageal reflux disease and asthma. Curr Opin Pulm Med. 2010;16(1):60–63. doi:10.1097/MCP.0b013e328332ca2f.
  • Harding SM, Sontag SJ. Asthma and gastroesophageal reflux. Am J Gastroenterol. 2000;95(1):S23–S32. doi:10.1016/S0002-9270(00)01075-3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.